Over the past 30 years, 18,000 clinical trials that have been registered in Australia, with the sector contributing $1.4 billion to Australia’s economy annually. Trials are a critical aspect of evidence-based medicine, and are essential for testing how new treatments, tests and vaccines will work. In New Zealand they contribute $146 million to the New Zealand economy.
Australia and New Zealand have established themselves as ideal locations to host clinical trials due to their diverse participant populations, sophisticated healthcare and research environments as well as government backed support. Both countries have adopted the International Council for Harmonisation (ICH) Guideline for Good Clinical Practice (GCP) to ensure all trials collect high quality and credible data that is internationally recognised.
To capitalise on this unique position and growth, a coordinated multi-site clinical research operation was missing.
Now, three of the largest clinical trial organisations across Australia and New Zealand have united to form Momentum Clinical Research – an end-to-end clinical research network with sites that have been operating for over 20 years. Combined, they have 13 site locations across the Trans-Tasman and are set to open more locations to allow more studies to take place and enable everyday people to access new and emerging therapies.
In February 2024, New Zealand’s renowned P3 Research joined forces with Australia’s AusTrials and Holdsworth House to form Momentum Clinical Research. The combined entity can now provide sponsors a single point of contact for their current 13 sites across the two countries,
Momentum Clinical Research aims to provide quick responses to feasibility requests, faster study starts and accelerated recruitment – all leading to the delivery of high-quality results for Phase 1b-IV clinical trials. Momentum Clinical Research has become the only Trans-Tasman network of clinical trial sites.
Australian Health Journal spoke with Aus Trials Research Director, Dr Munro Neville, on the Australian clinical trial landscape more broadly and reasons for creating a Trans-Tasman clinical research organisation.
Further growth in the industry is expected, with the Australian Government having pledged $750 million to increase clinical trial activity between 2022-2032. Similarly, the New Zealand Government has invested $98 million into health research funding from 2017-2027 to facilitate the conduct of clinical trials.
-
Reducing patient accessibility barriers in the clinical setting
Hannah McPierzie is a globally respected presenter, disability advocate, and educator who offers a unique perspective on disability and communication. She lives with Neurofibromatosis Type 2, a rare degenerative condition, and has two auditory brainstem implants. After 15 years teaching in the disability sector, Hannah acquired disability herself in 2020, when life-saving surgery left her deafblind.
-
Michelle Fenwick – Northern Health
The outskirts of Melbourne is experiencing significant population growth over the next 10 years and Northern Health has taken preemptive steps to ensure the supply of new talented healthcare staff as well as develop the culture of the workplace.
Michelle Fenwick, the Executive Director of Northern Health spoke with our reporter Anne Dao on the challenges of this urban growth over the past 3 years. By 2031 the region is expected to increase in population by 63%. Added to this is hiring and training the right workforce to align with the clinical care needs of people coming into the healthcare centres.
Culture is forming in a growing organisation with approximately 70% of staff having been at Northern Health less than 4 years. However there is opportunity for clinical staff to accelerate their career in such an environment
-
Getting the conversation going on the connection between oral health and chronic conditions
Dr. Carol Tran is an Oral Health Therapist and co-founder of Oral Health Home, an organisation focused on innovative, prevention-oriented oral health education and outreach. She is a Past President of Dental Hygienists Association of Australia (DHAA) and currently is the Scientific Program Chair, for upcoming congress in October 2025, for the newly formed Oral Health Association of Australia (OHAA).
